Avraham Havron
CIK: 0001971756
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Havron Avraham
Havron Avraham (SEC CIK 0001971756) files insider reports with the SEC as Director of CollPlant Biotechnologies Ltd (CLGN) and Director of Enlivex Ltd. (ENLV).
Signal8 holds 2 ownership filings by Havron Avraham, all Form 3s, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Havron Avraham's filings is in NESS ZIONA.
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Lask Alisa, Director